These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4308016)

  • 41. [Kinetic analyses of acetylcholine release from motor nerve terminals].
    Maeno T
    Nihon Seirigaku Zasshi; 1992; 54(3):91-107. PubMed ID: 1316962
    [No Abstract]   [Full Text] [Related]  

  • 42. The actions of benzoquinonium in the isolated cat tenuissimus muscle.
    Christ DD; Blaber LC
    J Pharmacol Exp Ther; 1968 Mar; 160(1):159-65. PubMed ID: 4295669
    [No Abstract]   [Full Text] [Related]  

  • 43. Bound acetylcholine in the nerve ending particles.
    Takeno K; Nishio A; Yanagiya I
    J Neurochem; 1969 Jan; 16(1):47-52. PubMed ID: 4887536
    [No Abstract]   [Full Text] [Related]  

  • 44. Facilitation by 3,4-diaminopyridine of regenerative acetylcholine release from mouse motor nerve.
    Hong SJ; Chang CC
    Br J Pharmacol; 1990 Dec; 101(4):793-8. PubMed ID: 1964819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutual dependence of calcitonin-gene related peptide and acetylcholine release in neuromuscular preparations.
    Kimura I; Okazaki M; Nojima H
    Eur J Pharmacol; 1997 Jul; 330(2-3):123-8. PubMed ID: 9253944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physostigmine, but not neostigmine, inhibits acetylcholine release.
    Alderdice MT
    Brain Res; 1979 Dec; 178(2-3):596-9. PubMed ID: 228798
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of propranolol on the isolated phrenic nerve-diaphragm preparation of the rat.
    Paradelis AG; Theocharidis NC; Logaras G
    Arzneimittelforschung; 1973 Jan; 23(1):38-40. PubMed ID: 4353375
    [No Abstract]   [Full Text] [Related]  

  • 48. Involvement of protein kinases in the upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats.
    Plomp JJ; Molenaar PC
    J Physiol; 1996 May; 493 ( Pt 1)(Pt 1):175-86. PubMed ID: 8735703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromuscular blocking action of cadmium and manganese in isolated frog striated muscles.
    Toda N
    Eur J Pharmacol; 1976 Nov; 40(1):67-75. PubMed ID: 186278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of muscle metabolites on neuromuscular transmission and muscle fatigue].
    Drabkina TM
    Fiziol Zh Im I M Sechenova; 1994 Sep; 80(9):52-60. PubMed ID: 7536583
    [No Abstract]   [Full Text] [Related]  

  • 51. The continual administration of neostigmine and the neuromuscular junction.
    Gillies JD; Allen J
    Proc Aust Assoc Neurol; 1976; 13():149-53. PubMed ID: 1029001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myasthenia gravis as a receptor disorder.
    Drachman DB; Kao I; Pestronk A; Toyka KV
    Ann N Y Acad Sci; 1976; 274():226-34. PubMed ID: 786108
    [No Abstract]   [Full Text] [Related]  

  • 53. Low-frequency neuromuscular depression is a consequence of a reduction in nerve terminal Ca2+ currents at mammalian motor nerve endings.
    Silinsky EM
    Anesthesiology; 2013 Aug; 119(2):326-34. PubMed ID: 23535502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ways in which chemicals can affect cholinergic nerve endings].
    Prozorovskiĭ VB
    Usp Fiziol Nauk; 1980; 11(2):26-48. PubMed ID: 6249048
    [No Abstract]   [Full Text] [Related]  

  • 55. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

  • 57. The actions of cholinergic drugs on motor nerve terminals.
    Miyamoto MD
    Pharmacol Rev; 1977 Sep; 29(3):221-47. PubMed ID: 28538
    [No Abstract]   [Full Text] [Related]  

  • 58. Feedback modulation of acetylcholine release from motor nerve.
    Chang CC; Hong SJ
    Proc Natl Sci Counc Repub China B; 1989 Apr; 13(2):71-82. PubMed ID: 2555830
    [No Abstract]   [Full Text] [Related]  

  • 59. The kinetics of transmitter release in myasthenia gravis. 3. An electrophysiological analysis of the release of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1973; 13(2):145-73. PubMed ID: 4354573
    [No Abstract]   [Full Text] [Related]  

  • 60. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.